Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berlan

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Fundamental & Clinical Pharmacology|January 1, 1995
Beta 3-adrenoceptors in the cardiovascular systemM Berlan, J Galitzky, J L Montastruc
British Journal of Pharmacology|September 1, 1989
Effects of yohimbine on submaxillary salivation in dogsP Montastruc, M Berlan, J L Montastruc
Trends in Pharmacological Sciences|July 1, 1992
Pharmacological prospects for alpha 2-adrenoceptor antagonist therapyM Berlan, J L Montastruc, M Lafontan
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dogM Taouis, M Berlan, P Montastruc, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonistsJ Galitzky, P Mauriege, M Berlan, et al.
European Journal of Clinical Investigation|April 1, 1987
Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequencesP Mauriege, J Galitzky, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002J Galitzky, D Larrouy, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical locationM Taouis, M Berlan, P Montastruc, et al.
Journal of Lipid Research|November 1, 1981
Effects of catecholamines on free fatty acid release from bone marrow adipose tissueM A Tran, T L Dang, M Berlan
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1985
Lack of desensitization of alpha-2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidineA Villeneuve, C Carpene, M Berlan, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Fundamental & Clinical Pharmacology|January 1, 1995
Beta 3-adrenoceptors in the cardiovascular systemM Berlan, J Galitzky, J L Montastruc
British Journal of Pharmacology|September 1, 1989
Effects of yohimbine on submaxillary salivation in dogsP Montastruc, M Berlan, J L Montastruc
Trends in Pharmacological Sciences|July 1, 1992
Pharmacological prospects for alpha 2-adrenoceptor antagonist therapyM Berlan, J L Montastruc, M Lafontan
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dogM Taouis, M Berlan, P Montastruc, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonistsJ Galitzky, P Mauriege, M Berlan, et al.
European Journal of Clinical Investigation|April 1, 1987
Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequencesP Mauriege, J Galitzky, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002J Galitzky, D Larrouy, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical locationM Taouis, M Berlan, P Montastruc, et al.
Journal of Lipid Research|November 1, 1981
Effects of catecholamines on free fatty acid release from bone marrow adipose tissueM A Tran, T L Dang, M Berlan
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1985
Lack of desensitization of alpha-2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidineA Villeneuve, C Carpene, M Berlan, et al.
Pageof 15